Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Related Articles by Review for PubMed (Select 16083521)

1.
2.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
3.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
4.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
5.

[Interest of the use of pindolol in the treatment of depression: review].

Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.

Encephale. 2003 Jul-Aug;29(4 Pt 1):338-50. Review. French.

PMID:
14615704
6.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

PMID:
10446737
7.

Efficacy and tolerability of controlled-release paroxetine.

Golden RN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:176-86. Review.

PMID:
14566210
8.

Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials.

Serretti A, Gibiino S, Drago A.

J Affect Disord. 2011 Jul;132(1-2):14-25. doi: 10.1016/j.jad.2010.08.018. Epub 2010 Sep 21. Review.

PMID:
20863574
9.

A review of the evidence for the efficacy and safety of trazodone in insomnia.

Mendelson WB.

J Clin Psychiatry. 2005 Apr;66(4):469-76. Review.

PMID:
15816789
10.

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.

Stein DJ, Davidson J, Seedat S, Beebe K.

Expert Opin Pharmacother. 2003 Oct;4(10):1829-38. Review.

PMID:
14521492
11.

[Trazodone--its multifunctional mechanism of action and clinical use].

Frecska E.

Neuropsychopharmacol Hung. 2010 Dec;12(4):477-82. Review. Hungarian.

12.

Paroxetine controlled release.

Bang LM, Keating GM.

CNS Drugs. 2004;18(6):355-64; discussion 365-6. Review.

PMID:
15089103
13.

Rediscovering trazodone for the treatment of major depressive disorder.

Fagiolini A, Comandini A, Catena Dell'Osso M, Kasper S.

CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5. Review. Erratum in: CNS Drugs. 2013 Aug;27(8):677.

14.

Paroxetine in the treatment of generalised anxiety disorder.

Snyderman SH, Rynn MA, Bellew K, Rickels K.

Expert Opin Pharmacother. 2004 Aug;5(8):1799-806. Review.

PMID:
15264994
15.

Overview of USA controlled trials of trazodone in clinical depression.

Feighner JP, Boyer WF.

Psychopharmacology (Berl). 1988;95 Suppl:S50-3. Review.

PMID:
3133715
16.

Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.

Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson SJ.

Psychiatry Res. 2003 Sep 30;120(2):179-90. Review.

PMID:
14527649
17.

Paroxetine: an overview of dosage, tolerability, and safety.

Jenner PN.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:69-80. Review.

PMID:
1431015
18.

Paroxetine treatment of depression in late life.

Reynolds CF 3rd.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:123-34. Review.

PMID:
14566207
19.

Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.

DeVane CL.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:29-41. Review.

PMID:
14566199
20.

Paroxetine treatment of major depressive disorder.

Keller MB.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:42-52. Review.

PMID:
14566200
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk